HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B.

AbstractOBJECTIVE:
To investigate whether the mechanism of a combined surfactant and inhaled nitric oxide (iNO) in improvement of oxygenation and mitigation of lung injury is associated with suppression of nuclear transcription factor kappa B (NF-kappaB) in the lung tissue of ventilated rabbits with meconium aspiration.
METHODS:
Adult rabbits (weight 2.0-3.5 kg, n = 33) were anesthetized, intratracheally received human meconium, and were subjected to pressure support ventilation for 30-60 min to induce hypoxemic respiratory failure and lung injury. They were then treated for 6 h in groups: control animals; rabbits receiving iNO; animals receiving surfactant (100 mg/kg), and rabbits receiving both iNO and surfactant. iNO was delivered continuously by mass flow controller in sequence at 1, 10, 20, and 40 ppm each for 60 min at 30-min intervals.
RESULTS:
Improvement in oxygenation and lung mechanics was found in the animals receiving both iNO and surfactant, associated with a marked response to iNO at 10 and 20 ppm (p < 0.05), a significantly higher ratio of disaturated phosphatidylcholine to total proteins, a lower surface tension of phospholipids from bronchoalveolar lavage fluid, a lower wet-to-dry lung weight ratio and lower lung injury scores, and better alveolar aeration. The iNO- and surfactant-treated groups had only transient or moderate-to-intermediate improvement in the associated parameters. The expression of NF-kappaB in lung tissue was enhanced in the control group, attenuated in the groups treated with either iNO or surfactant, and significantly suppressed in the group receiving both iNO and surfactant.
CONCLUSION:
Improvements of lung mechanics and gas exchange and mitigation of lung injury by the combined surfactant and iNO are related to suppression of NF-kappaB expression in lung tissue of ventilated rabbits with hypoxemic respiratory failure.
AuthorsXiaowei Hu, Lei Cao, Li Kuei Lam, Liewei Zhu, Chunbao Guo, Bo Sun
JournalBiology of the neonate (Biol Neonate) Vol. 87 Issue 2 Pg. 73-81 ( 2005) ISSN: 0006-3126 [Print] Switzerland
PMID15692188 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2005 S. Karger AG, Basel
Chemical References
  • NF-kappa B
  • Phosphatidylcholines
  • Phospholipids
  • Pulmonary Surfactants
  • Nitric Oxide
Topics
  • Animals
  • Bronchoalveolar Lavage Fluid (chemistry)
  • Disease Models, Animal
  • Humans
  • Hypoxia
  • Infant, Newborn
  • Lung (pathology, physiopathology)
  • Lung Diseases (drug therapy, etiology, physiopathology)
  • Meconium Aspiration Syndrome (complications)
  • NF-kappa B (analysis)
  • Nitric Oxide (administration & dosage)
  • Phosphatidylcholines (analysis)
  • Phospholipids (analysis)
  • Pulmonary Surfactants (administration & dosage)
  • Rabbits
  • Respiration, Artificial
  • Respiratory Insufficiency (drug therapy, etiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: